580 filings
ARS
2023 FY
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Annual report to shareholders
7:10am
DEFA14A
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Additional proxy soliciting materials
7:05am
DEF 14A
SYRS
Syros Pharmaceuticals Inc.
Definitive proxy
23 Apr 24
7:01am
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
4
David Roth
5 Apr 24
Syros Pharmaceuticals / David Roth ownership change
4:30pm
144
David Roth
3 Apr 24
Notice of proposed sale of securities
4:02pm
4
Kristin Stephens
2 Apr 24
Syros Pharmaceuticals / Kristin Stephens ownership change
5:01pm
4
SYRS
Syros Pharmaceuticals Inc.
2 Apr 24
Syros Pharmaceuticals / Nancy A Simonian ownership change
4:59pm
4
David Roth
2 Apr 24
Syros Pharmaceuticals / David Roth ownership change
4:58pm
4
SYRS
Syros Pharmaceuticals Inc.
2 Apr 24
Syros Pharmaceuticals / Gerald E Quirk ownership change
4:57pm
4
Jason Haas
2 Apr 24
Syros Pharmaceuticals / Jason Haas ownership change
4:54pm
4
Conley Chee
2 Apr 24
Syros Pharmaceuticals / Conley Chee ownership change
4:52pm
144
David Roth
2 Apr 24
Notice of proposed sale of securities
4:14pm
S-8
SYRS
Syros Pharmaceuticals Inc.
27 Mar 24
Registration of securities for employees
7:04am
10-K
2023 FY
SYRS
Syros Pharmaceuticals Inc.
Annual report
27 Mar 24
6:49am
SC 13G
Blue Owl Capital Holdings LP
14 Feb 24
Syros Pharmaceuticals / Blue Owl Capital ownership change
8:56pm
SC 13G/A
Avidity Partners Management LP
13 Feb 24
Syros Pharmaceuticals / Avidity Partners Management ownership change
8:22pm
SC 13G/A
SYRS
Syros Pharmaceuticals Inc.
13 Feb 24
Syros Pharmaceuticals / Ally Bridge MedAlpha Master Fund ownership change
7:02pm
SC 13G/A
Bain Capital Life Sciences Fund II, L.P.
13 Feb 24
Syros Pharmaceuticals / Bain Capital Life Sciences Fund II ownership change
6:59pm
SC 13G/A
Artal International S.C.A.
9 Feb 24
Syros Pharmaceuticals / Artal International S.C.A. ownership change
5:08pm